A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

NCT02671435 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: Monalizumab
DRUG: Durvalumab
DRUG: Cetuximab
DRUG: mFOLFOX6
DRUG: Bevacizumab

Sponsor

MedImmune LLC